Scientific Research | Novartis

Media Release
Sep 14, 2023
Novartis Kisqali® reduced the risk of cancer recurrence while maintaining quality of life in patients diagnosed with early breast cancer
Story
Nov 01, 2022
A scientist from the start – Q&A with NIBR President Fiona Marshall
Story
Oct 13, 2022
In neuroscience, “an inflection point in knowledge and technology”
Media Release
Mar 08, 2022
Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases
Story
Dec 06, 2021
When it comes to cancer, there’s power in a good partner
Story
Nov 12, 2021
Stopping this coronavirus – and the next one
Story
Nov 08, 2021
Solving the puzzle of immunotherapy
Media Release
Nov 05, 2020
Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
Media Release
Nov 06, 2020
Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS)
Media Release
Dec 17, 2020
Novartis builds on commitment to addressing need in neuropsychiatric disorders with Cadent Therapeutics acquisition
Media Release
Dec 09, 2019
Novartis global survey uncovers profound and often under-reported effects on sickle cell disease patients
Media Release
Mar 26, 2020
Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation